# Nephrogenic Systemic Fibrosis With Gadollinum

> **NCT01359345** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Imam Khomeini Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Nephrogenic Systemic Fibrosis
- Renal Failure

## Interventions

- **DRUG:** gadollinum

## Key facts

- **NCT ID:** NCT01359345
- **Lead sponsor:** Imam Khomeini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2011-05
- **Final completion:** 2012-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359345, "Nephrogenic Systemic Fibrosis With Gadollinum". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01359345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*